CPHI - China Pharma Holdings, Inc.
| Previous Close | 0.2387 |
| Open | 0.2350 |
| Bid | 0.2342 x 3100 |
| Ask | 0.2610 x 4000 |
| Day's Range | 0.2314 - 0.2429 |
| 52 Week Range | 0.2000 - 0.5800 |
| Volume | 39,734 |
| Avg. Volume | 108,776 |
| Market Cap | 11M |
| Beta (3Y Monthly) | 1.71 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.2190 |
| Earnings Date | Aug 15, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.00 |
- PR Newswire
China Pharma Holdings, Inc. Reports Third Quarter 2019 Financial Results
HAIKOU CITY, China , Nov. 15, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation ...
- Simply Wall St.
Introducing China Pharma Holdings (NYSEMKT:CPHI), A Stock That Climbed 37% In The Last Three Years
Buying a low-cost index fund will get you the average market return. But if you invest in individual stocks, some are...
- Simply Wall St.
Our Take On China Pharma Holdings, Inc.'s (NYSEMKT:CPHI) CEO Salary
In 2005 Zhilin Li was appointed CEO of China Pharma Holdings, Inc. (NYSEMKT:CPHI). This report will, first, examine...
- PR Newswire
China Pharma Holdings, Inc. Has Entered into A Memorandum of Understanding With World Health Advanced Technologies, Ltd.
HAIKOU CITY, China, Sept. 11, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," "CPHI", the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that it has entered into a Memorandum of Understanding (MOU) and the Addendum with World Health Advanced Technologies, Ltd (W.H.A.T.) to advance the scientific success of ENERCEL® on an exclusive basis in China. Chinese government has had the foresight to approve and develop the Free Trade Zone of Hainan Island.
- Thomson Reuters StreetEvents
Edited Transcript of CPHI earnings conference call or presentation 15-Aug-19 12:30pm GMT
Q2 2019 China Pharma Holdings Inc Earnings Call
- PR Newswire
China Pharma Holdings, Inc. Reports Second Quarter 2019 Financial Results
HAIKOU, China , Aug. 15, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation ...
- Thomson Reuters StreetEvents
Edited Transcript of CPHI earnings conference call or presentation 15-May-19 12:30pm GMT
Q1 2019 China Pharma Holdings Inc Earnings Call
- PR Newswire
China Pharma Holdings, Inc. Reports First Quarter 2019 Financial Results
HAIKOU, China , May 15, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation ...
- PR Newswire
CPHI to Hold First Quarter 2019 Earnings Conference Call On Wednesday, May 15, 2019 at 8:30 a.m. ET
HAIKOU, China , May 7, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE MKT: CPHI), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary ...
- PR Newswire
China Pharma Holdings, Inc. Reports Fiscal Year 2018 Financial Results
HAIKOU, China , March 29, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation ...
- Investopedia
Top 3 Healthcare Penny Stocks for 2018
These three healthcare penny stocks are poised for positive performance in the final quarter of 2018.
